NASDAQ:NXST - Nasdaq - US65336K1034 - Common Stock - Currency: USD
Mentions: META
Walgreens downgraded, Cava Group upgraded: Wall Street's top analyst calls
Shares of local broadcasting and digital media company Nexstar (NASDAQ:NXST) jumped 12.5% in the morning session after the company reported impressive fourth-quarter 2024 results that beat analysts' revenue estimates, driven by a sharp increase in political ad spending. EBITDA also beat Wall Street's expectations, fueled by revenue growth and disciplined cost management. On the other hand, its EPS missed. Overall, this was a mixed yet decent quarter.
Shares of local broadcasting and digital media company Nexstar (NASDAQ:NXST) jumped 12.5% in the morning session after the company reported impressive fourth-quarter 2024 results that beat analysts' revenue estimates, driven by a sharp increase in political ad spending. EBITDA also beat Wall Street's expectations, fueled by revenue growth and disciplined cost management. On the other hand, its EPS missed. Overall, this was a mixed yet decent quarter.
Local broadcasting and digital media company Nexstar (NASDAQ:NXST) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.1% year on year to $1.49 billion. Its GAAP profit of $7.56 per share was 6.2% below analysts’ consensus estimates.
Local broadcasting and digital media company Nexstar (NASDAQ:NXST) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.1% year on year to $1.49 billion. Its GAAP profit of $7.56 per share was 6.2% below analysts’ consensus estimates.
Over the past six months, Nexstar Media’s shares (currently trading at $152.86) have posted a disappointing 13.9% loss, well below the S&P 500’s 7.7% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Media executives see the possibility for more mergers and deregulation enabling the growth of broadcast and TV empires with the election of Republican Donald Trump to the US presidency.
Mentions: WBD